Franklin Lakes, NJ—BD Biosciences, a segment of BD (Becton, Dickinson and Company), today announced plans to expand manufacturing in Puerto Rico and to begin production of selected reagent products there starting in 2007.The $42 million capital investment project is expected to create over 100 new positions at the Cayey, Puerto Rico facility, which currently supports […]
Philadelphia, PA – Thermo Electron Corporation (NYSE:TMO) today introduced Migration Agent, a professional services and software solution that reduces risk and overcomes business challenges when migrating from any existing laboratory information management system (LIMS) to a Thermo LIMS. Migration Agent employs services personnel for project management and implementation, as well as an extract, transform and […]
CARLSBAD, Calif.–Invitrogen Corporation (Nasdaq:IVGN), a leading life sciences company, today announced the extension of an RNAi research service agreement with Procter & Gamble Pharmaceuticals, Inc. (P&GP), a division of The Procter & Gamble Company (NYSE:PG). The research service agreement is now in its fourth year and will continue through December 2006. Through use of Invitrogen’s […]
-Companies to Investigate Development of Another Novel Microfluidic System- HERCULES, Calif. and HOPKINTON, Mass.– Bio-Rad Laboratories, Inc. (Amex: BIO and BIOb) and Caliper Life Sciences, Inc. (Nasdaq: CALP) today announced a new collaboration, under which the companies will study the feasibility of developing a new microfluidics system platform. Details of the new product concept are […]
Fullerton, California, – Beckman Coulter, Inc. introduces Cell Lab Quanta SC – the second offering in its new family of affordable flow cytometers for drug discovery and basic clinical research. The Quanta SC combines side light scatter detection and a third fluorescent channel with Coulter volume measurement to deliver accurate, multiparameter cell counting and sizing. […]
SANTA CLARA, Calif..–Affymetrix Inc. (Nasdaq:AFFX) today announced the completion of its acquisition of privately held ParAllele BioScience, Inc., a provider of highly-scalable technology for comprehensive genetic studies. In connection with the completion of the acquisition, ParAllele stockholders will receive approximately $120.8 million in the form of approximately 2.29 million shares of Affymetrix common stock and […]
LAFAYETTE, Colo. — Dharmacon, Inc., a business unit of the Fisher Biosciences group, and the world’s leading supplier of innovative RNA and RNA interference (RNAi) research products, today announced a collaboration to develop a new class of therapeutic agents based on RNA interference with Alcon Research, Ltd. and Alcon Manufacturing, Ltd., affiliates of Alcon, Inc. […]
HAMPTON, N.H.–On behalf of its Biosciences group, Fisher Scientific International Inc. has launched a five-year collaboration with the University of Michigan to develop new tools for genomic and proteomic research. The collaboration promotes opportunities for Fisher to combine its expertise with research at the Center for Chemical Genomics (CCG) within the University of Michigan’s Life […]
Austin, TX, USA––Ambion, Inc., an Austin-based life sciences company that develops technologies for RNA analysis, and GE Healthcare, a unit of General Electric Company (NYSE: GE), today announced that they had entered into a license and supply agreement under which GE Healthcare will manufacture for Ambion microRNA (miRNA) microarrays utilizing GE Healthcare’s CodeLink™ Bioarray technology. […]
AUSTIN, Texas, Luminex Corporation (Nasdaq: LMNX – News) today announced the immediate availability of the Luminex 200, the latest advancement of Luminex’s line of microsphere-based multiplexed detection instruments based on the Company’s proprietary xMAP® technology. The Luminex 200 is designed to meet the multiplexed testing needs of the clinical and research laboratory professional. The Luminex […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
